CLDN4 and ovarian carcinoma: While the current work establishes that claudins can indeed be present in the peripheral circulation of ovarian cancer patients, several important issues will need to be clarified in subsequent studies before claudin-4 can be considered a viable biomarker for ovarian cancer detection.